微芯生物：CS08399片临床试验申请获得受理。

Core Viewpoint - Microchip Biotech's clinical trial application for CS08399 has been accepted, indicating progress in its drug development pipeline [1] Group 1 - The acceptance of the clinical trial application marks a significant milestone for Microchip Biotech in advancing its research and development efforts [1] - CS08399 is expected to address unmet medical needs in its targeted therapeutic area, potentially enhancing the company's market position [1]